ceo of swiss drugmaker novartis outlines some major industry trends for 2024
Published 6 months ago • 2.1K plays • Length 2:05
Download video MP4
Download video MP3
Similar videos
-
3:29
novartis generated $40 billion in innovative medicine sales, says ceo
-
4:54
novartis ceo: confident about continued sales growth for rest of year
-
6:12
novartis ceo: expect continued growth in 2023
-
2:53
novartis ceo on the development of ai tech in health care
-
3:42
novartis ceo vasant narasimhan on building trust with society
-
5:53
novartis expects 'strong momentum' going into second half, says ceo vasant narasimhan
-
5:20
'attractive' growth ahead for novo nordisk, ceo says
-
4:55
chinese stocks likely to outperform in 2024: fidelity
-
4:03
weekly jobless claims fall to 233,000, less than expected, in a positive sign for labor market
-
6:13
novo nordisk ceo on treating diabetes and obesity, and challenges facing the industry
-
7:01
novartis ceo: nations pulling back on health care spending ‘has long-term consequences'
-
5:50
the labor market is slowing slightly but healthy overall, says evercore's roger altman
-
3:33
novartis starts strategic review of sandoz generic drug unit: ceo
-
4:17
novartis ceo: we expect our six key drugs to grow ahead of analyst expectations
-
2:38
infineon ceo discusses launch of new chip plant in malaysia
-
3:45
neuberger berman's dan flax on buying the tech sector dip
-
0:45
novartis ceo: company set to become a pure play, innovative medicine business after sandoz spin off
-
4:37
novartis positioning is now best-suited for long-term gains and returns after spin-off, says ceo
-
4:36
2024 cnbc disruptor 50: octopus ceo on the global energy transition
-
0:28
novartis acquiring cancer drug developer morphosys for €2.7 billion
-
9:48
novartis ceo: growth drivers performing well, but product exclusivity losses creating headwinds
-
3:04
novartis ceo: spinoffs will see us succeed as a pure-play innovative medicines company
Clip.africa.com - Privacy-policy